STAT3 Mutations are Associated With Differential Treatment Responses to Methotrexate and Cyclophosphamide in T-Large Granular Lymphocyte Leukemia

被引：0
|
作者：
Tran, Danh T. [1 ]
Elghawy, Omar [2 ]
Shemo, Bryna C. [3 ]
Feith, David J. [3 ]
Loughran, Thomas P., Jr. [3 ]
机构：
[1] Univ Virginia, Med Ctr, Charlottesville, VA USA
[2] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
[3] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
TCL; T-large granular lymphocyte leukemia; methotrexate; cyclophosphamide; treatment response;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TCL-154
引用
收藏
页码：S465 / S466
页数：2
相关论文
共 50 条
  • [31] Reversible T-large granular lymphocyte expansion and neutropenia associated with adalimumab therapy
    Athina Theodoridou
    Charalambos Kartsios
    Efthalia Yiannaki
    Dimitra Markala
    Lucas Settas
    Rheumatology International, 2006, 27 : 201 - 202
  • [32] Reversible T-large granular lymphocyte expansion and neutropenia associated with adalimumab therapy
    Theodoridou, Athina
    Kartsios, Charalambos
    Yiannaki, Efthalia
    Markala, Dimitra
    Settas, Lucas
    RHEUMATOLOGY INTERNATIONAL, 2006, 27 (02) : 201 - 202
  • [33] Discovery of STAT5b Mutations and Small Subclones of STAT3 Mutations in Large Granular Lymphocytic (LGL) Leukemia
    Rajala, Hanna L. M.
    Eldfors, Samuli
    Kuusanmaki, Heikki
    Andersson, Emma I.
    van Adrichem, Arjan J.
    Lagstrom, Sonja
    Olson, Thomas
    Jerez, Andres
    Clemente, Michael J.
    Zhang, Dan
    Awwad, Andy
    Pihlman, Markus
    Ellonen, Pekka
    Kallioniemi, Olli
    Wennerberg, Krister
    Porkka, Kimmo
    Maciejewski, Jaroslaw P.
    Loughran, Thomas P., Jr.
    Heckman, Caroline A.
    Mustjoki, Satu
    BLOOD, 2012, 120 (21)
  • [34] STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia
    Zhi-Yuan Qiu
    Lei Fan
    Li Wang
    Chun Qiao
    Yu-Jie Wu
    Jian-Feng Zhou
    Wei Xu
    Jian-Yong Li
    Journal of Hematology & Oncology, 6
  • [35] Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
    Rosamilio, R.
    Giudice, V.
    Ferrara, I.
    Annunziata, S.
    Pezzullo, L.
    Villani, G.
    Baldi, C.
    Guariglia, R.
    Rocco, M.
    Selleri, C.
    TRANSLATIONAL MEDICINE AT UNISA, 2016, 15 : 80 - 83
  • [36] STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia
    Qiu, Zhi-Yuan
    Fan, Lei
    Wang, Li
    Qiao, Chun
    Wu, Yu-Jie
    Zhou, Jian-Feng
    Xu, Wei
    Li, Jian-Yong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [37] STAT3 mutations in "gray-zone" cases of T-cell large granular lymphocytic leukemia associated with autoimmune rheumatic diseases
    Gorodetskiy, Vadim
    Sidorova, Yulia
    Biderman, Bella
    Kupryshina, Natalia
    Ryzhikova, Natalya
    Sudarikov, Andrey
    FRONTIERS IN MEDICINE, 2022, 9
  • [38] DEEP SEQUENCING REVEALS SMALL SUBCLONES OF STAT3 MUTATIONS IN LARGE GRANULAR LYMPHOCYTIC LEUKEMIA
    Rajala, H.
    Ellonen, P.
    Lagstrom, S.
    Clemente, M.
    Olson, T.
    Andersson, E.
    Eldfors, S.
    Jerez, A.
    Zhang, D.
    Awwad, A.
    Kallioniemi, O.
    Porkka, K.
    Heckman, C.
    Loughran, T.
    Maciejewski, J.
    Mustjoki, S.
    HAEMATOLOGICA, 2013, 98 : 460 - 461
  • [39] TARGETED ACTIVATION OF THE TYROSINE PHOSPHATASE SHP-1 COUNTERACTS STAT3-MEDIATED SURVIVAL MECHANISM IN T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA
    Calabretto, G.
    Pagano, M. A.
    Tibaldi, E.
    Teramo, A.
    Dell'Amico, L.
    Barila, G.
    Trimarco, V.
    Vicenzetto, C.
    Gasparini, V. R.
    Tonini, A.
    Facco, M.
    Semenzato, G.
    Brunati, A. M.
    Zambello, R.
    HAEMATOLOGICA, 2020, 105 : S60 - S61
  • [40] STAT3 mutations are frequent in CD30+T-cell lymphomas and T-cell large granular lymphocytic leukemia
    Ohgami, R. S.
    Ma, L.
    Merker, J. D.
    Martinez, B.
    Zehnder, J. L.
    Arber, D. A.
    LEUKEMIA, 2013, 27 (11) : 2244 - 2247
12345